Page 12 - Advancing Translational Science News Today : Breaking News, Live Updates & Top Stories | Vimarsana

RSV Resurgence Likely in Wake of COVID-19

The impact of respiratory syncytial virus (RSV) will likely be greater in 2021 and 2022 in the United States than in previous years as a result of the ongoing COVID-19 pandemic.

New yorkUnited statesLenore jarvisYale universityNational centerInfectious diseases national institutes of healthNational institute of allergyNational institutes of healthMedscape coronavirus resource centerGeorge washington universityRoadmap for medical researchCoronavirus resourceZhe zhengNew havenNational instituteNational institutes

Asparagine Predicts Survival in Female Colorectal Cancer

Evidence for sex-related differences in colorectal cancer prognosis is not new, but now a new study points to these differences in primary tumor metabolite profiles.

United statesNew havenYale universityXinyi shenLingeng luYuping caiNational centerYale school of public healthNational institutes of healthAmerican cancer society researchYale schoolPublic healthNational institutesAdvancing translational scienceColorectal cancerAlignant neoplasia

New study predicts how SARS-CoV-2 evades vaccines

Models future SARS-CoV-2 mutations and forecasts their ability to evade immune defenses developed by vaccines and antibody-based treatments

Boston universityUnited statesAmos hostetterJonathan abrahamKatherine nabelNational centerHarvard pilgrim health care instituteUs centers for diseaseNational institutes of healthMassachusetts consortium on pathogen readinessBoston university school of medicineHarvard medical schoolHarvard mit md programAbbvie bioresearch centerChleck family foundationBlavatnik institute

SARS-CoV-2 variants are evolving new ways to evade antibodies, vaccines

This article is part of Harvard Medical School’s continuing coverage of medicine, biomedical research, medical education, and policy related to the

Boston universityUnited statesAmos hostetterJonathan abrahamAnthony griffithsKatherine nabelLindsay mckayNational emerging infectious diseases laboratoriesNational centerHarvard pilgrim health care instituteUs centers for diseaseNational institutes of healthMassachusetts consortium on pathogen readinessBoston university school of medicineHarvard medical schoolAbbvie bioresearch center

Inhaled steroid keeps COVID-19 patients with mild to moderate disease out of the hospital - UB Now: News and views for UB faculty and staff

Inhaled steroid keeps COVID-19 patients with mild to moderate disease out of the hospital - UB Now: News and views for UB faculty and staff
buffalo.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from buffalo.edu Daily Mail and Mail on Sunday newspapers.

United statesMichaels blaissCaryng morseRenoj varugheseCovis pharmaWanda phipatanakulYaneicy gonzalez rojasDavidj kosterNational centerResearch newsVerus clinical research corporationTranslational science instituteHarvard medical schoolDepartment of emergency medicineBiomedical sciencesCollege of georgia at augusta university